New Model Enables Better Decisions, Drives Organic Growth
BEACHWOOD, Ohio – Kalypso, the world’s premier innovation consulting firm, today announced the launch of PPM Nova, a practical portfolio and pipeline management (PPM) model for product development and innovation. PPM Nova is a fast-track model for improving innovation portfolio visibility and increasing pipeline value.
Based on leading practices and expertise, PPM Nova accelerates the adoption of a robust innovation process with a flexible design that integrates portfolio, phase gate, resource, program and idea management practices. The model includes metrics, reporting, valuation techniques, business process flows and decision making structures for these capabilities. This practical model can be easily and rapidly deployed, tailored and validated—either on its own or enabled in enterprise PPM systems.
“For any enterprise system implementation to be successful, companies must focus on business processes, content and people in addition to technology, and this is even more important with portfolio and pipeline management,” said Jim Brown, president and founder of Tech-Clarity. “Pre-defined best practices and metrics like those in PPM Nova can help companies maximize the value from portfolio management in a short timeframe.”
Companies that use PPM Nova are able to monitor innovation investments and align them with strategy, proactively manage innovation budget and resource constraints, and more effectively communicate strategic objectives and priorities. PPM Nova also accelerates time-to-value for leading PPM software through pre-configured solutions.
About Kalypso
Kalypso is the world's premier innovation consulting firm, helping clients improve performance, drive profitability and create sustainable results by delivering on the promise of innovation. The people of Kalypso are leading business professionals who combine unparalleled expertise in innovation, product development, and product lifecycle management (PLM) with a depth of experience in the consumer goods, high technology, manufacturing, medical device, life sciences and retail industries.